Video

Q&A With Fred Poordad From the Texas Liver Institute: Ally 1 Study Looks at Treatments for Patients with Liver Transplant

Author(s):

For patients who have undergone a liver transplant or have severe liver disease finding the right medications can be critical in their overall care.

For patients who have undergone a liver transplant or have severe liver disease finding the right medications can be critical in their overall care.

Fred Poordad, MD, from the Texas Liver Institute discussed the results of the study at the 2015 International Liver Congress in Vienna.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.